Attention-deficit/hyperactivity disorder (ADHD) is the most frequently diagnosed neurodevelopmental disorder; 6.4 million children and adolescents have been diagnosed with ADHD as of 2011. However, only 3.5 million children and adolescents are taking medication for ADHD. Adolescents with ADHD are much less willing to pursue or adhere to medication or psychosocial therapy, often because of their perceptions of side effects or perceived value of treatment, which places them at greater risk for difficulties at school, work, and home environments. Providing adolescents with increased autonomy through patient-centered approaches can increase their involvement and ability to manage their ADHD symptoms and treatment.
Keywords: Adolescents; Attention-deficit/hyperactivity disorder; DSM-V; Nonpharmacologic approaches; Nonstimulant medication; Pharmacologic approaches; Shared decision making; Stimulant medication.
Copyright © 2015 Elsevier Inc. All rights reserved.